Biologic Drugs

May 15, 2022

The need for sustainability and early considerations of a lyophilization strategy grow more pertinent on the back of growing biologics volume.

May 15, 2022

CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.

April 25, 2022

EMA has granted Novo Nordisk a positive scientific opinion on human insulin with more flexible storage without refrigeration.

April 12, 2022

Dupixent has been approved by the EC for children aged 6 to 11 years with severe asthma with type 2 inflammation.

April 08, 2022

FDA has granted Priority Review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in hospitalized adults.

April 08, 2022

NIH has announced four new grant awards to fund new tuberculosis research advancement centers.

April 02, 2022

The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.

April 02, 2022

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.

March 10, 2022

Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.

February 23, 2022

Alvea has begun preclinical testing of a scalable, shelf-stable DNA vaccine against SARS-CoV-2 variants.